Arcturus Therapeutics Holdings Inc. Contracts & Agreements

45 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fifth Amendment to Lease, by and between Arcturus Therapeutics, Inc. and ARE-SD Region No. 44, LLC, dated July 12, 2024
Lease Agreements
Arcturus Therapeutics Holdings Inc.
2024
First Amendment to Credit Agreement and First Amendment to Revolving Line of Credit, dated June 26, 2024, by and between Arcturus Therapeutics, Inc. and Wells Fargo Bank, National...
Credit Agreements
Arcturus Therapeutics Holdings Inc.
2024
Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Arcturus Therapeutics Holdings Inc.
2024
Amendment Number Two to Collaboration and License Agreement, dated March 29, 2024, by and between Arcturus Therapeutics, Inc. and Seqirus Inc
Collaboration Agreements
Arcturus Therapeutics Holdings Inc.
2024
Description of Registrants Securities
Arcturus Therapeutics Holdings Inc.
2024
Amendment Number One to Collaboration and License Agreement, dated August 3, 2023, by and between Arcturus Therapeutics, Inc. and Seqirus Inc
Collaboration Agreements
Arcturus Therapeutics Holdings Inc.
2023
Amendment No. 4 to Letter Agreement, dated September 25, 2023, by and between Arcturus Therapeutics, Inc. and the Cystic Fibrosis Foundation
Arcturus Therapeutics Holdings Inc.
2023
CREDIT AGREEMENT
Credit Agreements
Arcturus Therapeutics Holdings Inc.
2023
SECURITY AGREEMENT (SECURITIES ACCOUNT)
Security Agreements
Arcturus Therapeutics Holdings Inc.
2023
REVOLVING LINE OF CREDIT NOTE
Credit Agreements
Arcturus Therapeutics Holdings Inc.
2023
Amendment No. 1 to Controlled Equity Offering Sales Agreement
Sales Agreements
Arcturus Therapeutics Holdings Inc.
2023
Study Support Agreement effective October 31, 2022 by and between Arcturus Therapeutics, Inc. and Vinbiocare Biotechnology Joint Stock Company
Stock Agreements
Arcturus Therapeutics Holdings Inc.
2022
Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
DE
2022
Sixth Amendment to Loan and Security Agreement, dated April 19, 2022, by and between Arcturus Therapeutics, Inc. and Western Alliance Bank
Loan Agreements
Arcturus Therapeutics Holdings Inc.
2022
Description of Registrants Securities
Arcturus Therapeutics Holdings Inc.
2022
Fifth Amendment to Loan and Security Agreement, dated October 27, 2021, by and between Arcturus Therapeutics, Inc. and Western Alliance Bank
Loan Agreements
Arcturus Therapeutics Holdings Inc.
2021
Lease, by and between Arcturus Therapeutics, Inc. and TPSC IX, LLC, dated September 29, 2021
Lease Agreements
Arcturus Therapeutics Holdings Inc.
2021
Technology License and Technical Support Agreement, signed July 29, 2021 and effective July 30, 2021, by and between Arcturus Therapeutics, Inc. and Vinbiocare Biotechnology Joint...
Stock Agreements
Arcturus Therapeutics Holdings Inc.
2021
Framework Drug Substance Supply Agreement, signed July 29, 2021 and effective July 30, 2021, by and between Arcturus Therapeutics, Inc. and Vinbiocare Biotechnology Joint Stock...
Stock Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
CA
2021
Arcturus Therapeutics Holdings Inc. Severance Policy for Executives
Severance Agreements
Arcturus Therapeutics Holdings Inc.
2021
Description of Registrants Securities
Arcturus Therapeutics Holdings Inc.
Biotechnology
2021
SECOND AMENDMENT TO LEASE
Lease Agreements
Arcturus Therapeutics Holdings Inc.
2021
THIRD AMENDMENT TO LEASE
Lease Agreements
Arcturus Therapeutics Holdings Inc.
2021
Underwriting Agreement, dated December 7, 2020, by and among Arcturus Therapeutics Holdings Inc., Piper Sandler & Co., Guggenheim Securities, LLC and Wells Fargo Securities, LLC
Underwriting Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
NY
2020
Fourth Amendment to Loan and Security Agreement, dated December 1, 2020
Loan Agreements
Arcturus Therapeutics Holdings Inc.
2020
Supply Agreement, dated August 17, 2020, between Arcturus Therapeutics, Inc. and the Israeli Ministry of Health
Supply Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
DE
2020
Manufacturing Support Agreement, dated November 7, 2020, between Arcturus Therapeutics Holdings, Inc. and the Economic Development Board of Singapore
Development Agreements
Arcturus Therapeutics Holdings Inc.
2020
Underwriting Agreement, dated July 28, 2020, by and among Arcturus Therapeutics Holdings Inc., Citigroup Global Markets Inc., Guggenheim Securities, LLC, and Barclays Capital Inc
Underwriting Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
NY
2020
Underwriting Agreement, dated April 16, 2020, by and between Arcturus Therapeutics Holdings Inc. and Guggenheim Securities, LLC
Underwriting Agreements
Arcturus Therapeutics Holdings Inc.
2020
Sales Agreement, dated as of March 27, 2020, between the Company and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Arcturus Therapeutics Holdings Inc.
2020
Form of Indemnification Agreement
Indemnification Agreements
Arcturus Therapeutics Holdings Inc.
2020
Lease Agreement, by and between Arcturus Therapeutics Holdings Inc. and ARE-SD Region No. 44, LLC dated February 1, 2020
Lease Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
2020
Acceptance Letter, dated March 4, 2020, between Arcturus Therapeutics Holdings Inc. and the Economic Development Board of Singapore
Development Agreements
Arcturus Therapeutics Holdings Inc.
2020
Third Amendment, dated October 30, 2019, by and between Western Alliance Bank, and Arcturus Therapeutics, Inc. to the Loan and Security Agreement dated as of October 12, 2018....
Loan Agreements
Arcturus Therapeutics Holdings Inc.
2019
Letter Agreement, dated September 23, 2019, between the Company and the Placement Agent
Arcturus Therapeutics Holdings Inc.
Biotechnology
NY
2019
Form of Securities Purchase Agreement, dated September 25, 2019, between the Company and the purchasers party thereto
Purchase Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
NY
2019
Amendment dated as of August 1, 2019, by and between Arcturus Therapeutics, Inc. and Cystic Fibrosis Foundation to that certain Development Program Letter Agreement of May 16, 2017
Development Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
2019
Amendment to Development and Option Agreement, dated July 26, 2019, by and between Arcturus Therapeutics, Inc. and CureVac AG
Development Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
NY
2019
Termination Agreement, dated July 26, 2019, by and between Arcturus Therapeutics, Inc. and CureVac AG
Termination Agreements
Arcturus Therapeutics Holdings Inc.
2019
Securities Purchase Agreement, dated August 2, 2019, between the Company and the Investor
Purchase Agreements
Arcturus Therapeutics Holdings Inc.
2019
Letter Agreement, dated July 26, 2019, between the Company and the Placement Agent
Arcturus Therapeutics Holdings Inc.
2019
Securities Purchase Agreement, dated August 1, 2019, between the Company and the Investors party thereto
Purchase Agreements
Arcturus Therapeutics Holdings Inc.
2019
Registration Rights Agreement, dated June 18, 2019, between the Company and Ultragenyx Pharmaceutical Inc
Registration Rights Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
DE
2019
Equity Purchase Agreement, dated June 18, 2019, between the Company and Ultragenyx Pharmaceutical Inc
Purchase Agreements
Arcturus Therapeutics Holdings Inc.
2019
Third Amendment, dated June 18, 2019 to Research Collaboration and License Agreement, dated October 26, 2015, as amended on October 17, 2017 and April 20, 2018, between the...
Collaboration Agreements
Arcturus Therapeutics Holdings Inc.
2019